| Fiscal period | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|
| Period End Date | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 9/30/2014 | 9/30/2013 | 9/30/2012 |
|---|
| Product sales | 72.32 | 73.99 | 70.39 | 45.33 | 40.65 | 12.97 | 4.63 | 5.32 | 1.16 |
| Royalty income | 110.48 | 112.90 | 142.93 | 153.88 | 99.04 | 8.26 | 10.71 | 8.36 | 1.38 |
| Other income | 5.00 | 9.00 | -- | 37.50 | 49.80 | 45.00 | 3.77 | -- | -- |
| Total Revenue | 187.80 | 195.89 | 213.31 | 236.71 | 189.48 | 66.23 | 19.10 | 13.68 | 2.54 |
| Cost of product sales | 33.65 | 47.89 | 42.37 | 33.71 | 35.79 | 7.76 | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- | 7.89 | 5.04 | 7.38 | 3.17 |
| Cost of royalty | 11.82 | 13.01 | 19.54 | 23.47 | 19.52 | -- | 6.67 | -- | -- |
| Research and development | 30.79 | 36.81 | 44.42 | 32.61 | 28.29 | 27.86 | 16.82 | 9.80 | 12.81 |
| Selling, general and administrative | 78.60 | 76.37 | 60.51 | 71.42 | 53.33 | 20.17 | 9.33 | 4.96 | 6.40 |
| Restructuring charge | 0.00 | 0.00 | 7.91 | 0.00 | -- | -- | -- | -- | -- |
| Legal settlement | -- | -- | -- | (1.65) | -- | -- | -- | -- | -- |
| Asset impairment charges | -- | -- | (2.70) | (7.24) | -- | -- | -- | -- | -- |
| Gain on sale of asset | -- | -- | -- | -- | 1.75 | -- | -- | -- | -- |
| Changes in fair value of contingent consideration | -- | -- | 0.76 | 7.38 | (0.96) | -- | -- | -- | -- |
| Total Operating Expenses | 154.85 | 174.08 | 176.70 | 162.72 | 136.13 | 63.67 | 37.86 | 22.13 | 22.37 |
| Income (Loss) from operations | 32.95 | 21.82 | 36.62 | 73.99 | 53.35 | 2.56 | (18.76) | (8.46) | (19.83) |
| Interest expense | 2.58 | 2.69 | 2.74 | 1.14 | 0.01 | 0.01 | 0.01 | 0.31 | 0.09 |
| Net proceeds from arbitration | -- | -- | -- | -- | -- | -- | -- | (4.05) | -- |
| Interest income | 0.56 | 2.17 | 0.16 | 0.09 | 0.08 | 0.03 | 0.03 | 0.00 | 0.03 |
| Other income/(expense), net | (8.26) | 0.70 | -- | -- | -- | -- | 0.04 | 0.00 | 0.01 |
| Deferred financing costs | -- | -- | -- | -- | -- | -- | -- | (0.10) | (0.02) |
| Amortization of debt discount | -- | -- | -- | -- | -- | -- | -- | (1.09) | (0.22) |
| Change in value of warrant liability | -- | -- | -- | -- | -- | -- | (0.57) | (1.05) | -- |
| Loss on subscription loan settlement | -- | -- | -- | -- | -- | -- | -- | -- | (0.05) |
| Total other income/(expense), net | (10.28) | 0.18 | (2.58) | (1.05) | 0.08 | 0.01 | (0.52) | 1.51 | (0.33) |
| Income (loss) before income tax | 22.68 | 22.00 | 34.04 | 72.95 | 53.43 | 2.57 | (19.27) | (6.95) | (20.16) |
| Income tax (benefit) expenses | 10.69 | 7.69 | 2.14 | 21.00 | (28.03) | 0.00 | (1.30) | (0.90) | (0.78) |
| Net Income (loss) | -- | -- | -- | 51.94 | -- | -- | (17.98) | (6.05) | (19.38) |
| Dividends on Series A, B, B-1 and C Convertible Preferred Stock | -- | -- | -- | -- | -- | -- | 1.67 | 3.84 | 3.93 |
| Net income (loss) attributable to common stockholders | 11.99 | 14.31 | 31.90 | 51.94 | 81.45 | 2.57 | (19.64) | (9.89) | (23.32) |
| Income (Loss) per share attributable to common stockholders Basic | 0.89 | 1.04 | 2.16 | 3.44 | 5.24 | 0.17 | (1.97) | (3.25) | (14.11) |
| Income (Loss) per share attributable to common stockholders Diluted | 0.87 | 1.01 | 2.09 | 3.27 | 4.96 | 0.16 | (1.97) | (3.25) | (14.11) |
| WEIGHTED AVERAGE COMMON SHARES OUTSTANDING BASIC | 13.48 | 13.76 | 14.77 | 15.10 | 15.53 | 15.25 | 9.96 | 3.04 | 1.65 |
| WEIGHTED AVERAGE COMMON SHARES OUTSTANDING DILUTED | 13.77 | 14.14 | 15.28 | 15.91 | 16.43 | 16.25 | 9.96 | 3.04 | 1.65 |